Photodynamic Therapy and Focal Laser Photocoagulation in Chronic Central Serous Chorioretinopathy
To compare the treatment efficacy of photodynamic therapy (PDT) and focal laser photocoagulation in chronic central serous chorio-retinopathy (CSC).
Central serous chorioretinopathy (CSC) is the fourth most common retinopathy after age-related macular degeneration, diabetic retinopathy and retinal vein occlusions. 1 CSC is a retinal disorder characterized clinically by detachment of neurosensory retina at the posterior pole, usually involving the macula. Acute CSC generally resolves spontaneously with minimal sequelae. However, chronic CSC can result in significant visual loss. Although, other treatment modalities have been suggested for central serous retinopathy, the major treatment options for CSC have included argon laser photocoagulation or photodynamic therapy (PDT). 2 In conclusion, when compared with focal laser photocoagulation, PDT more effective absorption of subretinal fluid at 1 month after treatment. However, no difference of BCVA improvement and resolution period was found between PDT and focal laser photocoagulation. Both treatments are beneficial in patients with chronic CSC. Focal laser photocoagulation can be a good treatment option in a aspect of cost-effectiveness and conveniency.
PDT was performed in 23 eyes of 23 patients, and focal laser photocoagulation was performed in 17 eyes of 17 patients, and all patients were followed up more than 6 months( Table 1) . Location of leaking point and appearance of leakage was no statistically significant difference between two groups (Table 2) Both groups showed significant improvement of BCVA at 1 month and 6 months after the treatment, however, there was no statistically significant difference of BCVA improvement between two groups (Table 3 ,4). SRF and PED of both groups were partially or completely resolved. Resolution of SRF was better in PDT Group at 1 month after the treatment, however, no statistically significant difference of resolution period was found between the groups. (Table 5 A retrospective study in a clinical practice setting of forty eyes of 40 patients with chronic CSC which were treated PDT or focal laser photocoagulation were recruited for this study from March 2011 to December 2013. Mean change in best corrected visual acuity (BCVA), whether resolution of subretinal fluid (SRF) and pigment epithelium detachment (PED) or not, recurrence rate, and complications were analyzed. PDT was done at dilated choroidal vessel showed on indocyanine green angiography with the mode setting of 1/2~2/3 power, full time, and full dose. Focal laser photocoagulation was done at early hyper-fluorescent spot detected by fluorescein angio-graphy with the 100-200 mW power and 80-100ms time setting, and when the leaking point is found within 350 um of macula, indirect focal laser photocoagulation was done at the periphery (Figure 1 ). 
